logo
Plus   Neg
Share
Email

Kroger Health Gets FDA Emergency Use Authorization For COVID-19 Test Home Collection Kit

Kroger Health, the healthcare division of The Kroger Co. (KR), said that the U.S. Food and Drug Administration has granted Emergency Use Authorization for the COVID-19 Test Home Collection Kit.

The company said the new testing model combines at-home convenience with telehealth technology, with most results confirmed in less than 72 hours.

The company noted that the COVID-19 Test Home Collection Kit will be available to frontline associates across Kroger's Family of Companies, beginning this week.

In partnership with Gravity Diagnostics, Kroger Health plans to process more than 60,000 tests per week by the end of July.

The home collection kit includes a nasal swab, transport vial, instruction sheet, prepaid shipping label, and packing materials for return shipment of the sample to the laboratory.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Humana Inc. (HUM) reported second quarter adjusted earnings per share of $12.56 compared to $6.05, previous year. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $10.27, for the quarter. Analysts' estimates typically exclude special items. Second... H-E-B has issued an all-store recall for Blue Cheese Salmon Burgers citing the presence of an undeclared allergen, the U.S. Food and Drug Administration announced. The products contain wheat, a known allergen, which is not declared on the product label. Consumers with allergy or severe sensitivity to wheat may get serious or life-threatening allergic reaction if they consume these products. The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co.'s (KODK) announcement of a $765 million government loan to make ingredients for Covid-19 drugs, the Wall Street Journal reported citing people familiar with the matter.
Follow RTT